Atossa Therapeutics (ATOS) Q2 2026 Earnings

May 8Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.11
-0.76
-0.4
-0.05

Details

Expected EPS
-0.99
Actual EPS
-1.11
Surprise EPS
-0.12
Surprise Percent
-12.12%

Description

⁨Atossa Therapeutics⁩ (⁦ATOS⁩) has reported earnings of ⁦-1.11⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts